SGR recently posted this on another board. He has met with management and attended shareholder's meetings.
"I can talk about that. As it stands, there are companies that want the machine since last year. I have no idea as to which companies, however, it was mentioned last December at the share holders meeting. Sales should not be a problem. The plan is to sell the machines to a 3rd party by whom the MIT 1000 will be leased to those wanting it. Thus, each lease will be a sale for MMTC. According to Jeffrey, contacts for sales have been progressing since the Rhode Island show as well. So, we could see sales beginning very soon. Each machine will sell for $30,000 and the profits will be split with OSI Systems, manufactures of the MIT 1000. That is, unless something has changed since our meeting in December.
Here's the thing: If anyone remains concerned about sales, they can simply tally up the market for it. It's called market research. I have spent countless days and months doing market research on the MIT 1000 and find the market much too large for even 20 companies of this caliber to fill. I went to the lab twice and watched the machine in action as part of my research. The end result of the laborious task or follow-up for possible sales for the MIT 1000 leaves me speechless; the crater of need can be seen as a tsunami of pathogens flooding the food market, including fish and human-borne pathogens as well. As time passes, even pet foods have crossed over to humans through handling the product where pathogens are breath and handled in dry pet foods. In fact, each incident of a pathogen outbreak can result in multiple sales . . . just as we see in the news today with the present cantaloupe scare with Salmonella in many different states. In summary, sales should do very well, IMO.
So, to answer your question, sales should do very nicely and reps should make a nice income from it. Reps are already in the process, from what I understand. "